<DOC>
	<DOCNO>NCT01841567</DOCNO>
	<brief_summary>The overall rationale study evaluate clinical performance potential Mepilex Border Post-Op ability minimise risk blistering , maceration less dressing change due high absorption capacity . This study part Post Market Clinical Follow-Up ( PMCF ) .</brief_summary>
	<brief_title>Post Market Clinical Follow-up Study</brief_title>
	<detailed_description />
	<criteria>Inclusion Criteria 1 . Age 45 year 2 . Have expect total length stay 4 day 3 . Undergoing elective primary arthroplasty hip knee 4 . Undergoing hip surgery standard access 5 . Give write informed consent participate Exclusion Criteria 1 . Dressing size fit incision area 2 . Known allergy hypersensitivity component dress 3 . Multitrauma 4 . Undergoing arthroplasty due tumour 5 . Fractures 6 . Wound surgical site prior surgery 7 . Neurological deficit operate side 8 . Subject documented skin disease time enrolment , judge investigator 9 . Previously enrol present investigation 10 . Subject include ongoing investigation present , judge investigator .</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>hip</keyword>
	<keyword>knee</keyword>
</DOC>